Further Investigation of the Role of ACYP2 and WFS1 Pharmacogenomic Variants in the Development of Cisplatin-Induced Ototoxicity in Testicular Cancer Patients

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-17-2810
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Variants in WFS1 and Other Mendelian Deafness Genes Are Associated With Cisplatin-Associated Ototoxicity

Clinical Cancer Research
Cancer ResearchOncology
2016English

The Role of Inherited TPMT and COMT Genetic Variation in Cisplatin-Induced Ototoxicity in Children With Cancer

Clinical Pharmacology and Therapeutics
Pharmacology
2013English

Corrigendum: Common Variants in ACYP2 Influence Susceptibility to Cisplatin-Induced Hearing Loss

Nature Genetics
Genetics
2015English

The Effect of Dexpanthenol on Ototoxicity Induced by Cisplatin

Clinical and Experimental Otorhinolaryngology
OtorhinolaryngologySurgery
2016English

Cisplatin-Induced Ototoxicity in Rats Is Driven by RIP3-Dependent Necroptosis

Cells
2019English

Protective Effect of L-Carnitine Against Cisplatin-Induced Testicular Toxicity in Rats

Al-Azhar Journal of Pharmaceutical Sciences
2016English

Cancer Treatment in Childhood and Testicular Function: The Role of the Somatic Environment

Endocrine Connections
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Common Variants in WFS1 Confer Risk of Type 2 Diabetes

Nature Genetics
Genetics
2007English

Mortality in Patients With Testicular Cancer: Report of the Anglia and Trent Testicular Tumour Groups.

BMJ
1986English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy